Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.15 USD | +0.59% | -0.96% | -42.71% |
05-07 | Lucien Selce Urges Aurinia Pharmaceuticals Board to Take Action to Enhance Shareholder Value | CI |
05-02 | Transcript : Aurinia Pharmaceuticals Inc., Q1 2024 Earnings Call, May 02, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.71% | 735M | |
+2.93% | 108B | |
+7.02% | 23.46B | |
-14.60% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-8.83% | 17.19B | |
+5.51% | 13.99B | |
+37.49% | 12.53B | |
+329.39% | 8.81B |
- Stock Market
- Equities
- AUPH Stock
- News Aurinia Pharmaceuticals Inc.
- HC Wainwright Adjusts Price Target on Aurinia Pharmaceuticals to $15 From $14, Maintains Buy Rating